Market Research Reports and Industry Reports

United States OffLabel Drugs Market & Forecast

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

Off–label prescribing of medicines is prevalent worldwide because it gives freedom to physicians to apply new therapeutic options based on the latest evidence. Although physicians may lawfully prescribe approved Drugs for any use consistent with available scientific data and proper medical practice, but unfortunately, this is done without adequate scientific data. Often, when the best available therapeutic option fails, patients demand new approach or new treatment which ultimately leads to off–label uses.
 
 Off–label use is very common in United States. United States Off–label Drugs demand has grown at a fast pace in the past decade and likely to grow in the forecasting period. It is likely that United States off–label market will cross the figure of 60 Billion by the year 2020. Central Nervous System (CNS) and Cancer off–label Drugs controls the largest market share of the total US off–label Drugs market. Anti–Infectives Off–Label Drugs Market and Anti–Ashmatics Off–Label Drugs together are expected to control close to 35% market share by 2020.
 
 Renub Research study titled “United States Off–Label Drugs Market & Forecast” report provides a comprehensive analysis of the emerging Off–Label Drugs market. The report also entails commonly prescribed Off–Label Drugs, Perspective of Physicians, Patients, Pharmaceutical Companies and Regulatory Authorities, Off–label Promotion Settlements under the False Claims Act. The report also studies Drivers and Challenges of United States Off–Label Drugs market. This 67 page report with 16 Figures and 1 Table studies 6 Off–Label Drugs Segment.
 
 The 6 Off–Label Drugs Segment Covered in the Report are as Follows:
 
 1. Cancer Off–Label Drugs
 2. Central Nervous System (CNS) Off–Label Drugs
 3. Anti–Ashmatics Off–Label Drugs
 4. Anti–Allergies Off–Label Drugs
 5. Anti–Hypertensives Off–Label Drugs
 6. Anti–Infectives Off–Label Drugs
 
 Data Sources
 
 This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
 
 Primary sources include industry surveys and telephonic interviews with industry experts.
 
 Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

 1. Executive Summary
 
 2. United States Off–Label Drugs Market & Forecast
 
 3. United States Off–Label Drugs Market Share & Forecast
 
 4. United States Off–Label Drugs Market – Segment wise
 4.1 United States – Cancer Off–Label Drugs Market & Forecast
 4.2 United States – Central Nervous System (CNS) Off–Label Drugs Market & Forecast
 4.3 United States – Anti–Ashmatics Off–Label Drugs Market & Forecast
 4.4 United States – Anti–Allergies Off–Label Drugs Market & Forecast
 4.5 United States – Anti–Hypertensives Off–Label Drugs Market & Forecast
 4.6 United States – Anti–Infectives Off–Label Drugs Market & Forecast
 
 5. Drugs Commonly Prescribed Off–Label
 
 6. Off–Label Use of Medicine & Different Perspectives
 6.1 Physicians Perspective
 6.1.1 Physicians’ Liability for Off–Label Prescriptions
 6.2 Patients Perspective
 6.3 Perspective of the Pharmaceutical Companies
 6.4 Perspective of Regulatory Agencies
 
 7. Off–Label Promotion Settlements Under The False Claims Act
 7.1 Year 2004
 7.2 Year 2005
 7.3 Year 2006
 7.4 Year 2007
 7.5 Year 2008
 7.6 Year 2009
 7.7 Year 2010
 7.8 Year 2011
 7.9 Year 2012
 7.10 Year 2013
 7.11 Year 2014
 
 8. United States Off–Label Drugs Market – Growth Drivers
 8.1 Clinical Practices and Application in the Off–Label Drugs
 8.2 Vulnerable Patient Populations: Information and Access
 8.3 Off–Label Promotion Reform
 
 9. United States Off–Label Drugs Market – Challenges
 9.1 Lack of Regulation & Information of the United States Off–Label Drugs Market
 9.2 Reimbursement
 9.3 Safety and Efficacy of Unapproved and Under Evaluated Use
 9.4 Point of View on Bioethical Off–Label Drugs Use
 9.5 Inaccuracy of Off–Label Clinical Publications


List Of Tables

Table 5–1: Commonly Prescribed Off–Label Drugs


List Of Figures

 Figure 2–1: United States – Off–Label Drugs Market (Billion US$), 2011 – 2014
 Figure 2–2: United States – Forecast for Off–Label Drugs Market (Billion US$), 2015 – 2020
 
 Figure 3–1: United States – Off–Label Drugs Market Share (Percent), 2011 – 2014
 Figure 3–2: United States – Forecast for Off–Label Drugs Market Share (Percent), 2015 – 2020
 
 Figure 4–1: United States – Cancer Off–Label Drugs Market (Billion US$), 2008 – 2014
 Figure 4–2: United States – Forecast for Cancer Off–Label Drugs Market (Billion US$), 2015 – 2020
 Figure 4–3: United States – Central Nervous System (CNS) Off–Label Drugs Market (Billion US$), 2009 – 2014
 Figure 4–4: United States – Forecast for Central Nervous System (CNS) Off–Label Drugs Market (Billion US$), 2015 – 2020
 Figure 4–5: United States – Anti–Ashmatics Off–Label Drugs Market (Billion US$), 2010 – 2014
 Figure 4–6: United States – Forecast for Anti–Ashmatics Off–Label Drugs Market (Billion US$), 2015 – 2020
 Figure 4–7: United States – Anti–Allergies Off–Label Drugs Market (Billion US$), 2011 – 2014
 Figure 4–8: United States – Forecast for Anti–Allergies Off–Label Drugs Market (Billion US$), 2015 – 2020
 Figure 4–9: United States – Anti–Hypertensives Off–Label Drugs Market (Billion US$), 2009 – 2014
 Figure 4–10: United States – Forecast for Anti–Hypertensives Off–Label Drugs Market (Billion US$), 2015 – 2020
 Figure 4–11: United States – Anti–Infectives Off–Label Drugs Market (Billion US$), 2008 – 2014
 Figure 4–12: United States – Forecast for Anti–Infectives Off–Label Drugs Market (Billion US$), 2015 – 2020


Gulf United Energy, Inc Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Gulf United Energy, Inc Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT

USD 200View Report

United States, EU, Japan, China, India and Southeast Asia Same-day Delivery Market Size, Status and Forecast 2021

Notes:Production, means the output of Same-day DeliveryRevenue, means the sales value of Same-day DeliveryThis report studies the global Same-day Delivery market, analyzes and researches the Same-day Delivery development status and

USD 3300View Report

United States Thaumatin Market Report 2016

Notes:Sales, means the sales volume of ThaumatinRevenue, means the sales value of ThaumatinThis report studies sales (consumption) of Thaumatin in United States market, focuses on the top players, with sales,

USD 3800View Report

United States, EU, Japan, China, India and Southeast Asia Same-day Delivery Market Size, Status and Forecast 2021

Notes:Production, means the output of Same-day DeliveryRevenue, means the sales value of Same-day DeliveryThis report studies the global Same-day Delivery market, analyzes and researches the Same-day Delivery development status and

USD 3300View Report

United States Thaumatin Market Report 2016

Notes:Sales, means the sales volume of ThaumatinRevenue, means the sales value of ThaumatinThis report studies sales (consumption) of Thaumatin in United States market, focuses on the top players, with sales,

USD 3800View Report

United States Sludge-suspending Agent Market Report 2016

Notes:Sales, means the sales volume of Sludge-suspendingAgentRevenue, means the sales value of Sludge-suspendingAgentThis report studies sales (consumption) of Sludge-suspendingAgent in United States market, focuses on the top players, with sales,

USD 3800View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 1200
  • CD    $ 1300
  • Hard Copy    $ 1300
  • Site Licence    $ 1800
  • Enterprise Wide Licence    $ 1800
$ 1200

Reports Details

Published Date : Apr 2015
No. of Pages :67
Country :United States of America
Category :Healthcare
Publisher :Renub Research
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment